Interventional Systems (INS) is a pioneer in the surgical robotics space, specializing in B2B and OEM solutions for minimally invasive and percutaneous procedures. The company empowers its partners to integrate cutting-edge robotics into their portfolios, offering a fast and cost-effective path to market while eliminating the burdens of in-house R&D, manufacturing, and regulatory hurdles.
Its flagship product, Micromate™, is the world’s most versatile and affordable miniature robotic platform. Cleared for any 2D or 3D image-guided, needle-based procedure, Micromate™ supports multiple surgical specialties and a wide range of instruments while seamlessly integrating with third-party navigation systems. Designed for precision, portability, and ease of use, it brings the benefits of robotic assistance to practices of all sizes, from large hospitals to outpatient clinics and Ambulatory Surgery Centers (ASCs).
To foster continued innovation, INS collaborates with leading clinical sites across Europe and the U.S. via their Center of Excellence program. This initiative offers invaluable physician insights and unbiased clinical feedback to refine and improve its robotics solutions.
The company’s unique approach accelerates the adoption of surgical robotics, enabling partners to stay ahead in a rapidly evolving healthcare landscape while focusing on what they do best—serving patients.
Interventional Systems is headquartered in Kitzbühel, Austria, with offices in Austria, Germany, and Portugal.
Michael Vogele
